AlexandraGomez ArteagaMD

PubMed

• 3 citations
  Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.
  Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga, Tsiporah B Shore, Nina Orfali, Sebastian Mayer, Jingmei Hsu, Adrienne A Phi...> ;Transplantation and Cellular Therapy. 2023 Feb 1
• 1 citations
  Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!
  Alexandra Gomez-Arteaga, Koen van Besien> ;Leukemia & Lymphoma. 2021 Nov 24
• 1 citations
  Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.
  , , , , , , , , , , , , , , , > ;Leukemia & Lymphoma. 2021 Oct 13
• Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectations.
  Koen van Besien, Alexandra Gomez-Arteaga> ;Leukemia & Lymphoma. 2021 Sep 29
• 5 citations
  Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
  Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Ulrik...> ;Blood Advances. 2021 Sep 22
• 21 citations
  Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
  Michael J. Satlin, Liang Chen, Claire Douglass, Michael Hovan, Emily Davidson, Rosemary Soave, Marisa La Spina, Alexandra Gomez-Arteaga, Koen van Besien, Sebastian May...> ;Clinical Infectious Diseases. 2021 Oct 5
• 6 citations
  Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML.
  Amanda Lopez, Sanjay S. Patel, Julia T. Geyer, Joelle Racchumi, Amy Chadburn, Paul D. Simonson, Madhu M. Ouseph, Giorgio Inghirami, Nuria Mencia-Trinchant, Monica L. G...> ;Frontiers in Oncology. 2021 Aug 30
• 1 citations
  Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma
  Alexandra Gomez-Arteaga, Gunjan L. Shah, Raymond E. Baser, Michael Scordo, Josel D. Ruiz, Adam Bryant, Parastoo B. Dahi, Arnab K. Ghosh, Oscar B Lahoud, Heather Landau...> ;Biology of Blood and Marrow Transplantation. 2020 Nov 1
• 3 citations
  Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
  Alexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, Melissa M. Cushing, Usama Gergis, Jingmei Hsu, Yen-Michael S. Hsu, Sebastian Mayer, Adrienne A. Phillips, Stac...> ;Bone Marrow Transplantation. 2020 Jun 9
• 2 citations
  Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a c...
  Alexandra Gomez-Arteaga, Michael Scordo, Roni Tamari, Josel D. Ruiz, Ann A. Jakubowski, Esperanza B. Papadopoulos, Sergio Giralt, Miguel-Angel Perales, Hugo Castro-Mal...> ;Bone Marrow Transplantation. 2020 May 18
• 8 citations
  Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
  Alexandra Gomez-Arteaga, Boglarka Gyurkocza> ;Current Opinion in Hematology. 2020 Mar 1
• 3 citations
  Approaches to Targeting Cancer Stem Cells in Solid Tumors.
  Eloisi Caldas-Lopes, Alexandra Gomez-Arteaga, Monica L. Guzman> ;Current Stem Cell Research & Therapy. 2019 Jun 30
• 17 citations
  High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
  Alexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, Paul J. Christos, Usama Gergis, June Greenberg, Jingmei Hsu, Sebastian Mayer, Ruben Niesvizky, Roger N. Pears...> ;Bone Marrow Transplantation. 2019 Jun 12
• 18 citations
  Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation.
  Alexandra Gomez-Arteaga, Elizabeth Margolskee, Mike Wei, Koen van Besien, Giorgio Inghirami, Steven M. Horwitz> ;Leukemia & Lymphoma. 2019 Apr 18
• 6 citations
  Minimal Residual Disease in Acute Myeloid Leukemia.
  Alexandra Gomez-Arteaga, Monica L. Guzman> ;Advances in Experimental Medicine and Biology. 2018 Jan 1
• 6 citations
  Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.
  Peter J. Hosein, Jose D. Sandoval-Sus, Deborah Goodman, Alexandra Gomez Arteaga, Isildinha M. Reis, James E. Hoffman, Alexandra Stefanovic, Joseph D. Rosenblatt, Izido...> ;American Journal of Hematology. 2015 Jun 1
• Join now to see all

Abstracts/Posters

• Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
  Alexandra Gomez-Arteaga, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019